| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 209 | 482 | 294 | | Cost of Revenue |
-
|
-
|
-
| | | Gross Profit | 209 | 482 | 294 | | | Operating Expenses | | Research Development | 14,152 | 7,860 | 20,834 | | Selling General and Administrative | 5,746 | 4,867 | 5,042 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (19,689) | (12,245) | (25,582) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (372) | 672 | 709 | | Earnings Before Interest And Taxes | (20,061) | (11,573) | (24,873) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (20,061) | (11,573) | (24,873) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (20,061) | (11,573) | (24,873) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (20,061) | (11,573) | (24,873) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($20,061) | ($11,573) | ($24,873) |
|
1.48% Nasdaq 
Income Statement
